Vernakalant Hydrochloride (CAS No 748810-28-8) is an antiarrhythmic agent primarily used in biomedical research to explore cardiac electrophysiology It originates from efforts to develop treatments for atrial fibrillation by selectively targeting ion channels specifically potassium channels in cardiac tissue therefore stabilizing abnormal heart rhythms The compound s mechanism of action involves blocking atrial-specific potassium currents resulting in an effective restoration of normal rhythm without affecting ventricular tissues In vitro Vernakalant Hydrochloride exhibits activity typically in the nanomolar to low micromolar range Researchers commonly utilize it in cell models and animal studies to investigate cardiac disorders as well as in drug screening assays to assess its therapeutic potential and safety profile Experimental concentrations typically depend on the specific research design ensuring adequate testing conditions for various study parameters